nodes	percent_of_prediction	percent_of_DWPC	metapath
Chenodeoxycholic acid—Drostanolone—Estradiol—prostate cancer	0.29	1	CrCrCtD
Chenodeoxycholic acid—CYP3A4—prostate cancer	0.135	1	CbGaD
Chenodeoxycholic acid—UGT2B7—Epirubicin—prostate cancer	0.059	0.234	CbGbCtD
Chenodeoxycholic acid—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.04	0.158	CbGbCtD
Chenodeoxycholic acid—CYP3A4—Bicalutamide—prostate cancer	0.021	0.0832	CbGbCtD
Chenodeoxycholic acid—CYP3A4—Estramustine—prostate cancer	0.0195	0.0774	CbGbCtD
Chenodeoxycholic acid—CYP3A4—Flutamide—prostate cancer	0.0174	0.069	CbGbCtD
Chenodeoxycholic acid—CYP3A4—Abiraterone—prostate cancer	0.0174	0.069	CbGbCtD
Chenodeoxycholic acid—CYP3A4—Cabazitaxel—prostate cancer	0.0129	0.051	CbGbCtD
Chenodeoxycholic acid—CYP3A4—Estrone—prostate cancer	0.0126	0.0499	CbGbCtD
Chenodeoxycholic acid—CYP3A4—Ethinyl Estradiol—prostate cancer	0.0112	0.0444	CbGbCtD
Chenodeoxycholic acid—CYP3A4—Conjugated Estrogens—prostate cancer	0.00824	0.0326	CbGbCtD
Chenodeoxycholic acid—CYP3A4—Mitoxantrone—prostate cancer	0.00749	0.0296	CbGbCtD
Chenodeoxycholic acid—CYP3A4—Estradiol—prostate cancer	0.00723	0.0286	CbGbCtD
Chenodeoxycholic acid—CYP3A4—Prednisone—prostate cancer	0.00622	0.0246	CbGbCtD
Chenodeoxycholic acid—CYP3A4—Etoposide—prostate cancer	0.00472	0.0187	CbGbCtD
Chenodeoxycholic acid—CYP3A4—Docetaxel—prostate cancer	0.00432	0.0171	CbGbCtD
Chenodeoxycholic acid—NR1H4—prostate gland—prostate cancer	0.00394	0.146	CbGeAlD
Chenodeoxycholic acid—CYP3A4—Doxorubicin—prostate cancer	0.00322	0.0128	CbGbCtD
Chenodeoxycholic acid—CYP27A1—prostate gland—prostate cancer	0.00287	0.106	CbGeAlD
Chenodeoxycholic acid—NR1H4—renal system—prostate cancer	0.00269	0.0994	CbGeAlD
Chenodeoxycholic acid—UGT2B7—prostate gland—prostate cancer	0.00254	0.094	CbGeAlD
Chenodeoxycholic acid—CYP27A1—seminal vesicle—prostate cancer	0.00243	0.0898	CbGeAlD
Chenodeoxycholic acid—CYP27A1—renal system—prostate cancer	0.00196	0.0723	CbGeAlD
Chenodeoxycholic acid—CYP3A4—urine—prostate cancer	0.00193	0.0713	CbGeAlD
Chenodeoxycholic acid—CYP27A1—urethra—prostate cancer	0.00192	0.0711	CbGeAlD
Chenodeoxycholic acid—UGT2B7—renal system—prostate cancer	0.00173	0.0641	CbGeAlD
Chenodeoxycholic acid—CYP27A1—testis—prostate cancer	0.00126	0.0468	CbGeAlD
Chenodeoxycholic acid—NR1H4—lymph node—prostate cancer	0.00126	0.0466	CbGeAlD
Chenodeoxycholic acid—UGT2B7—testis—prostate cancer	0.00112	0.0414	CbGeAlD
Chenodeoxycholic acid—CYP27A1—lymph node—prostate cancer	0.000917	0.0339	CbGeAlD
Chenodeoxycholic acid—Drostanolone—SHBG—prostate cancer	0.000714	0.31	CrCbGaD
Chenodeoxycholic acid—Drostanolone—AR—prostate cancer	0.000626	0.272	CrCbGaD
Chenodeoxycholic acid—Drostanolone—CYP19A1—prostate cancer	0.000524	0.228	CrCbGaD
Chenodeoxycholic acid—CYP3A4—renal system—prostate cancer	0.000472	0.0175	CbGeAlD
Chenodeoxycholic acid—Ursodeoxycholic acid—CYP2E1—prostate cancer	0.000439	0.19	CrCbGaD
Chenodeoxycholic acid—Sinusitis—Doxorubicin—prostate cancer	2.77e-05	0.000166	CcSEcCtD
Chenodeoxycholic acid—Convulsion—Prednisone—prostate cancer	2.76e-05	0.000166	CcSEcCtD
Chenodeoxycholic acid—Visual impairment—Epirubicin—prostate cancer	2.76e-05	0.000166	CcSEcCtD
Chenodeoxycholic acid—Hypertension—Prednisone—prostate cancer	2.75e-05	0.000165	CcSEcCtD
Chenodeoxycholic acid—Rash—Mitoxantrone—prostate cancer	2.75e-05	0.000165	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Mitoxantrone—prostate cancer	2.75e-05	0.000165	CcSEcCtD
Chenodeoxycholic acid—Musculoskeletal discomfort—Docetaxel—prostate cancer	2.75e-05	0.000165	CcSEcCtD
Chenodeoxycholic acid—Headache—Mitoxantrone—prostate cancer	2.73e-05	0.000164	CcSEcCtD
Chenodeoxycholic acid—Hypotension—Capecitabine—prostate cancer	2.73e-05	0.000164	CcSEcCtD
Chenodeoxycholic acid—Insomnia—Docetaxel—prostate cancer	2.73e-05	0.000164	CcSEcCtD
Chenodeoxycholic acid—Arthralgia—Prednisone—prostate cancer	2.71e-05	0.000163	CcSEcCtD
Chenodeoxycholic acid—Myalgia—Prednisone—prostate cancer	2.71e-05	0.000163	CcSEcCtD
Chenodeoxycholic acid—Paraesthesia—Docetaxel—prostate cancer	2.71e-05	0.000163	CcSEcCtD
Chenodeoxycholic acid—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	2.69e-05	0.000162	CcSEcCtD
Chenodeoxycholic acid—Dyspnoea—Docetaxel—prostate cancer	2.69e-05	0.000161	CcSEcCtD
Chenodeoxycholic acid—Somnolence—Docetaxel—prostate cancer	2.68e-05	0.000161	CcSEcCtD
Chenodeoxycholic acid—Discomfort—Prednisone—prostate cancer	2.68e-05	0.000161	CcSEcCtD
Chenodeoxycholic acid—Eye disorder—Epirubicin—prostate cancer	2.67e-05	0.000161	CcSEcCtD
Chenodeoxycholic acid—Hypersensitivity—Etoposide—prostate cancer	2.67e-05	0.000161	CcSEcCtD
Chenodeoxycholic acid—Tinnitus—Epirubicin—prostate cancer	2.67e-05	0.00016	CcSEcCtD
Chenodeoxycholic acid—Haemoglobin—Doxorubicin—prostate cancer	2.66e-05	0.00016	CcSEcCtD
Chenodeoxycholic acid—Musculoskeletal discomfort—Capecitabine—prostate cancer	2.66e-05	0.00016	CcSEcCtD
Chenodeoxycholic acid—Cardiac disorder—Epirubicin—prostate cancer	2.66e-05	0.00016	CcSEcCtD
Chenodeoxycholic acid—Rhinitis—Doxorubicin—prostate cancer	2.66e-05	0.00016	CcSEcCtD
Chenodeoxycholic acid—Dyspepsia—Docetaxel—prostate cancer	2.65e-05	0.000159	CcSEcCtD
Chenodeoxycholic acid—Haemorrhage—Doxorubicin—prostate cancer	2.65e-05	0.000159	CcSEcCtD
Chenodeoxycholic acid—Insomnia—Capecitabine—prostate cancer	2.64e-05	0.000159	CcSEcCtD
Chenodeoxycholic acid—Pharyngitis—Doxorubicin—prostate cancer	2.63e-05	0.000158	CcSEcCtD
Chenodeoxycholic acid—Paraesthesia—Capecitabine—prostate cancer	2.62e-05	0.000157	CcSEcCtD
Chenodeoxycholic acid—Decreased appetite—Docetaxel—prostate cancer	2.62e-05	0.000157	CcSEcCtD
Chenodeoxycholic acid—Urinary tract disorder—Doxorubicin—prostate cancer	2.62e-05	0.000157	CcSEcCtD
Chenodeoxycholic acid—Oedema peripheral—Doxorubicin—prostate cancer	2.61e-05	0.000157	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal disorder—Docetaxel—prostate cancer	2.6e-05	0.000156	CcSEcCtD
Chenodeoxycholic acid—Asthenia—Etoposide—prostate cancer	2.6e-05	0.000156	CcSEcCtD
Chenodeoxycholic acid—Connective tissue disorder—Doxorubicin—prostate cancer	2.6e-05	0.000156	CcSEcCtD
Chenodeoxycholic acid—Dyspnoea—Capecitabine—prostate cancer	2.6e-05	0.000156	CcSEcCtD
Chenodeoxycholic acid—Oedema—Prednisone—prostate cancer	2.6e-05	0.000156	CcSEcCtD
Chenodeoxycholic acid—Fatigue—Docetaxel—prostate cancer	2.6e-05	0.000156	CcSEcCtD
Chenodeoxycholic acid—Angiopathy—Epirubicin—prostate cancer	2.6e-05	0.000156	CcSEcCtD
Chenodeoxycholic acid—Urethral disorder—Doxorubicin—prostate cancer	2.6e-05	0.000156	CcSEcCtD
Chenodeoxycholic acid—Nausea—Mitoxantrone—prostate cancer	2.59e-05	0.000156	CcSEcCtD
Chenodeoxycholic acid—Immune system disorder—Epirubicin—prostate cancer	2.59e-05	0.000155	CcSEcCtD
Chenodeoxycholic acid—Infection—Prednisone—prostate cancer	2.58e-05	0.000155	CcSEcCtD
Chenodeoxycholic acid—Mediastinal disorder—Epirubicin—prostate cancer	2.58e-05	0.000155	CcSEcCtD
Chenodeoxycholic acid—Pain—Docetaxel—prostate cancer	2.58e-05	0.000155	CcSEcCtD
Chenodeoxycholic acid—Constipation—Docetaxel—prostate cancer	2.58e-05	0.000155	CcSEcCtD
Chenodeoxycholic acid—Dyspepsia—Capecitabine—prostate cancer	2.57e-05	0.000154	CcSEcCtD
Chenodeoxycholic acid—Chills—Epirubicin—prostate cancer	2.57e-05	0.000154	CcSEcCtD
Chenodeoxycholic acid—Pruritus—Etoposide—prostate cancer	2.57e-05	0.000154	CcSEcCtD
Chenodeoxycholic acid—Shock—Prednisone—prostate cancer	2.56e-05	0.000154	CcSEcCtD
Chenodeoxycholic acid—Arrhythmia—Epirubicin—prostate cancer	2.56e-05	0.000154	CcSEcCtD
Chenodeoxycholic acid—Visual impairment—Doxorubicin—prostate cancer	2.55e-05	0.000153	CcSEcCtD
Chenodeoxycholic acid—Nervous system disorder—Prednisone—prostate cancer	2.55e-05	0.000153	CcSEcCtD
Chenodeoxycholic acid—Tachycardia—Prednisone—prostate cancer	2.54e-05	0.000152	CcSEcCtD
Chenodeoxycholic acid—Decreased appetite—Capecitabine—prostate cancer	2.54e-05	0.000152	CcSEcCtD
Chenodeoxycholic acid—Alopecia—Epirubicin—prostate cancer	2.53e-05	0.000152	CcSEcCtD
Chenodeoxycholic acid—Skin disorder—Prednisone—prostate cancer	2.53e-05	0.000152	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal disorder—Capecitabine—prostate cancer	2.52e-05	0.000151	CcSEcCtD
Chenodeoxycholic acid—Fatigue—Capecitabine—prostate cancer	2.52e-05	0.000151	CcSEcCtD
Chenodeoxycholic acid—Hyperhidrosis—Prednisone—prostate cancer	2.51e-05	0.000151	CcSEcCtD
Chenodeoxycholic acid—Constipation—Capecitabine—prostate cancer	2.5e-05	0.00015	CcSEcCtD
Chenodeoxycholic acid—Pain—Capecitabine—prostate cancer	2.5e-05	0.00015	CcSEcCtD
Chenodeoxycholic acid—Malnutrition—Epirubicin—prostate cancer	2.49e-05	0.00015	CcSEcCtD
Chenodeoxycholic acid—Feeling abnormal—Docetaxel—prostate cancer	2.48e-05	0.000149	CcSEcCtD
Chenodeoxycholic acid—Diarrhoea—Etoposide—prostate cancer	2.48e-05	0.000149	CcSEcCtD
Chenodeoxycholic acid—Anorexia—Prednisone—prostate cancer	2.48e-05	0.000149	CcSEcCtD
Chenodeoxycholic acid—Eye disorder—Doxorubicin—prostate cancer	2.48e-05	0.000149	CcSEcCtD
Chenodeoxycholic acid—Tinnitus—Doxorubicin—prostate cancer	2.47e-05	0.000148	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal pain—Docetaxel—prostate cancer	2.47e-05	0.000148	CcSEcCtD
Chenodeoxycholic acid—Cardiac disorder—Doxorubicin—prostate cancer	2.46e-05	0.000148	CcSEcCtD
Chenodeoxycholic acid—Flatulence—Epirubicin—prostate cancer	2.46e-05	0.000148	CcSEcCtD
Chenodeoxycholic acid—Tension—Epirubicin—prostate cancer	2.45e-05	0.000147	CcSEcCtD
Chenodeoxycholic acid—Nervousness—Epirubicin—prostate cancer	2.42e-05	0.000145	CcSEcCtD
Chenodeoxycholic acid—Back pain—Epirubicin—prostate cancer	2.41e-05	0.000145	CcSEcCtD
Chenodeoxycholic acid—Feeling abnormal—Capecitabine—prostate cancer	2.41e-05	0.000145	CcSEcCtD
Chenodeoxycholic acid—Angiopathy—Doxorubicin—prostate cancer	2.4e-05	0.000144	CcSEcCtD
Chenodeoxycholic acid—Dizziness—Etoposide—prostate cancer	2.4e-05	0.000144	CcSEcCtD
Chenodeoxycholic acid—Muscle spasms—Epirubicin—prostate cancer	2.4e-05	0.000144	CcSEcCtD
Chenodeoxycholic acid—Immune system disorder—Doxorubicin—prostate cancer	2.39e-05	0.000144	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal pain—Capecitabine—prostate cancer	2.39e-05	0.000143	CcSEcCtD
Chenodeoxycholic acid—Mediastinal disorder—Doxorubicin—prostate cancer	2.39e-05	0.000143	CcSEcCtD
Chenodeoxycholic acid—Abdominal pain—Docetaxel—prostate cancer	2.38e-05	0.000143	CcSEcCtD
Chenodeoxycholic acid—Body temperature increased—Docetaxel—prostate cancer	2.38e-05	0.000143	CcSEcCtD
Chenodeoxycholic acid—Chills—Doxorubicin—prostate cancer	2.38e-05	0.000143	CcSEcCtD
Chenodeoxycholic acid—Musculoskeletal discomfort—Prednisone—prostate cancer	2.37e-05	0.000142	CcSEcCtD
Chenodeoxycholic acid—Arrhythmia—Doxorubicin—prostate cancer	2.37e-05	0.000142	CcSEcCtD
Chenodeoxycholic acid—Insomnia—Prednisone—prostate cancer	2.35e-05	0.000141	CcSEcCtD
Chenodeoxycholic acid—Alopecia—Doxorubicin—prostate cancer	2.34e-05	0.000141	CcSEcCtD
Chenodeoxycholic acid—Paraesthesia—Prednisone—prostate cancer	2.33e-05	0.00014	CcSEcCtD
Chenodeoxycholic acid—Urticaria—Capecitabine—prostate cancer	2.32e-05	0.000139	CcSEcCtD
Chenodeoxycholic acid—Ill-defined disorder—Epirubicin—prostate cancer	2.31e-05	0.000139	CcSEcCtD
Chenodeoxycholic acid—Abdominal pain—Capecitabine—prostate cancer	2.31e-05	0.000139	CcSEcCtD
Chenodeoxycholic acid—Body temperature increased—Capecitabine—prostate cancer	2.31e-05	0.000139	CcSEcCtD
Chenodeoxycholic acid—Vomiting—Etoposide—prostate cancer	2.31e-05	0.000139	CcSEcCtD
Chenodeoxycholic acid—Malnutrition—Doxorubicin—prostate cancer	2.31e-05	0.000139	CcSEcCtD
Chenodeoxycholic acid—Anaemia—Epirubicin—prostate cancer	2.3e-05	0.000138	CcSEcCtD
Chenodeoxycholic acid—Dyspepsia—Prednisone—prostate cancer	2.29e-05	0.000137	CcSEcCtD
Chenodeoxycholic acid—Rash—Etoposide—prostate cancer	2.29e-05	0.000137	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Etoposide—prostate cancer	2.29e-05	0.000137	CcSEcCtD
Chenodeoxycholic acid—Headache—Etoposide—prostate cancer	2.27e-05	0.000137	CcSEcCtD
Chenodeoxycholic acid—Flatulence—Doxorubicin—prostate cancer	2.27e-05	0.000136	CcSEcCtD
Chenodeoxycholic acid—Tension—Doxorubicin—prostate cancer	2.26e-05	0.000136	CcSEcCtD
Chenodeoxycholic acid—Decreased appetite—Prednisone—prostate cancer	2.26e-05	0.000136	CcSEcCtD
Chenodeoxycholic acid—Malaise—Epirubicin—prostate cancer	2.25e-05	0.000135	CcSEcCtD
Chenodeoxycholic acid—Fatigue—Prednisone—prostate cancer	2.24e-05	0.000135	CcSEcCtD
Chenodeoxycholic acid—Nervousness—Doxorubicin—prostate cancer	2.24e-05	0.000135	CcSEcCtD
Chenodeoxycholic acid—Vertigo—Epirubicin—prostate cancer	2.24e-05	0.000134	CcSEcCtD
Chenodeoxycholic acid—Syncope—Epirubicin—prostate cancer	2.23e-05	0.000134	CcSEcCtD
Chenodeoxycholic acid—Leukopenia—Epirubicin—prostate cancer	2.23e-05	0.000134	CcSEcCtD
Chenodeoxycholic acid—Back pain—Doxorubicin—prostate cancer	2.23e-05	0.000134	CcSEcCtD
Chenodeoxycholic acid—Constipation—Prednisone—prostate cancer	2.22e-05	0.000134	CcSEcCtD
Chenodeoxycholic acid—Hypersensitivity—Docetaxel—prostate cancer	2.22e-05	0.000133	CcSEcCtD
Chenodeoxycholic acid—Muscle spasms—Doxorubicin—prostate cancer	2.22e-05	0.000133	CcSEcCtD
Chenodeoxycholic acid—Palpitations—Epirubicin—prostate cancer	2.2e-05	0.000132	CcSEcCtD
Chenodeoxycholic acid—Loss of consciousness—Epirubicin—prostate cancer	2.19e-05	0.000132	CcSEcCtD
Chenodeoxycholic acid—Cough—Epirubicin—prostate cancer	2.17e-05	0.000131	CcSEcCtD
Chenodeoxycholic acid—Asthenia—Docetaxel—prostate cancer	2.16e-05	0.00013	CcSEcCtD
Chenodeoxycholic acid—Convulsion—Epirubicin—prostate cancer	2.16e-05	0.00013	CcSEcCtD
Chenodeoxycholic acid—Nausea—Etoposide—prostate cancer	2.15e-05	0.000129	CcSEcCtD
Chenodeoxycholic acid—Hypertension—Epirubicin—prostate cancer	2.15e-05	0.000129	CcSEcCtD
Chenodeoxycholic acid—Hypersensitivity—Capecitabine—prostate cancer	2.15e-05	0.000129	CcSEcCtD
Chenodeoxycholic acid—Feeling abnormal—Prednisone—prostate cancer	2.14e-05	0.000129	CcSEcCtD
Chenodeoxycholic acid—Ill-defined disorder—Doxorubicin—prostate cancer	2.14e-05	0.000129	CcSEcCtD
Chenodeoxycholic acid—Pruritus—Docetaxel—prostate cancer	2.13e-05	0.000128	CcSEcCtD
Chenodeoxycholic acid—Anaemia—Doxorubicin—prostate cancer	2.13e-05	0.000128	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal pain—Prednisone—prostate cancer	2.13e-05	0.000128	CcSEcCtD
Chenodeoxycholic acid—Arthralgia—Epirubicin—prostate cancer	2.12e-05	0.000127	CcSEcCtD
Chenodeoxycholic acid—Chest pain—Epirubicin—prostate cancer	2.12e-05	0.000127	CcSEcCtD
Chenodeoxycholic acid—Myalgia—Epirubicin—prostate cancer	2.12e-05	0.000127	CcSEcCtD
Chenodeoxycholic acid—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	2.11e-05	0.000127	CcSEcCtD
Chenodeoxycholic acid—Discomfort—Epirubicin—prostate cancer	2.1e-05	0.000126	CcSEcCtD
Chenodeoxycholic acid—Asthenia—Capecitabine—prostate cancer	2.09e-05	0.000126	CcSEcCtD
Chenodeoxycholic acid—Malaise—Doxorubicin—prostate cancer	2.08e-05	0.000125	CcSEcCtD
Chenodeoxycholic acid—Dry mouth—Epirubicin—prostate cancer	2.07e-05	0.000125	CcSEcCtD
Chenodeoxycholic acid—Vertigo—Doxorubicin—prostate cancer	2.07e-05	0.000124	CcSEcCtD
Chenodeoxycholic acid—Syncope—Doxorubicin—prostate cancer	2.07e-05	0.000124	CcSEcCtD
Chenodeoxycholic acid—Urticaria—Prednisone—prostate cancer	2.07e-05	0.000124	CcSEcCtD
Chenodeoxycholic acid—Pruritus—Capecitabine—prostate cancer	2.07e-05	0.000124	CcSEcCtD
Chenodeoxycholic acid—Leukopenia—Doxorubicin—prostate cancer	2.06e-05	0.000124	CcSEcCtD
Chenodeoxycholic acid—Diarrhoea—Docetaxel—prostate cancer	2.06e-05	0.000124	CcSEcCtD
Chenodeoxycholic acid—Body temperature increased—Prednisone—prostate cancer	2.06e-05	0.000123	CcSEcCtD
Chenodeoxycholic acid—Abdominal pain—Prednisone—prostate cancer	2.06e-05	0.000123	CcSEcCtD
Chenodeoxycholic acid—Confusional state—Epirubicin—prostate cancer	2.05e-05	0.000123	CcSEcCtD
Chenodeoxycholic acid—Palpitations—Doxorubicin—prostate cancer	2.04e-05	0.000122	CcSEcCtD
Chenodeoxycholic acid—Oedema—Epirubicin—prostate cancer	2.03e-05	0.000122	CcSEcCtD
Chenodeoxycholic acid—Loss of consciousness—Doxorubicin—prostate cancer	2.03e-05	0.000122	CcSEcCtD
Chenodeoxycholic acid—Infection—Epirubicin—prostate cancer	2.02e-05	0.000121	CcSEcCtD
Chenodeoxycholic acid—Cough—Doxorubicin—prostate cancer	2.01e-05	0.000121	CcSEcCtD
Chenodeoxycholic acid—Shock—Epirubicin—prostate cancer	2e-05	0.00012	CcSEcCtD
Chenodeoxycholic acid—Convulsion—Doxorubicin—prostate cancer	2e-05	0.00012	CcSEcCtD
Chenodeoxycholic acid—Diarrhoea—Capecitabine—prostate cancer	2e-05	0.00012	CcSEcCtD
Chenodeoxycholic acid—Nervous system disorder—Epirubicin—prostate cancer	1.99e-05	0.00012	CcSEcCtD
Chenodeoxycholic acid—Dizziness—Docetaxel—prostate cancer	1.99e-05	0.00012	CcSEcCtD
Chenodeoxycholic acid—Thrombocytopenia—Epirubicin—prostate cancer	1.99e-05	0.00012	CcSEcCtD
Chenodeoxycholic acid—Hypertension—Doxorubicin—prostate cancer	1.99e-05	0.00012	CcSEcCtD
Chenodeoxycholic acid—Tachycardia—Epirubicin—prostate cancer	1.98e-05	0.000119	CcSEcCtD
Chenodeoxycholic acid—Skin disorder—Epirubicin—prostate cancer	1.98e-05	0.000119	CcSEcCtD
Chenodeoxycholic acid—Hyperhidrosis—Epirubicin—prostate cancer	1.97e-05	0.000118	CcSEcCtD
Chenodeoxycholic acid—Myalgia—Doxorubicin—prostate cancer	1.96e-05	0.000118	CcSEcCtD
Chenodeoxycholic acid—Arthralgia—Doxorubicin—prostate cancer	1.96e-05	0.000118	CcSEcCtD
Chenodeoxycholic acid—Chest pain—Doxorubicin—prostate cancer	1.96e-05	0.000118	CcSEcCtD
Chenodeoxycholic acid—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	1.95e-05	0.000117	CcSEcCtD
Chenodeoxycholic acid—Discomfort—Doxorubicin—prostate cancer	1.94e-05	0.000117	CcSEcCtD
Chenodeoxycholic acid—Anorexia—Epirubicin—prostate cancer	1.94e-05	0.000116	CcSEcCtD
Chenodeoxycholic acid—Dizziness—Capecitabine—prostate cancer	1.93e-05	0.000116	CcSEcCtD
Chenodeoxycholic acid—Dry mouth—Doxorubicin—prostate cancer	1.92e-05	0.000115	CcSEcCtD
Chenodeoxycholic acid—Vomiting—Docetaxel—prostate cancer	1.92e-05	0.000115	CcSEcCtD
Chenodeoxycholic acid—Hypersensitivity—Prednisone—prostate cancer	1.92e-05	0.000115	CcSEcCtD
Chenodeoxycholic acid—Rash—Docetaxel—prostate cancer	1.9e-05	0.000114	CcSEcCtD
Chenodeoxycholic acid—Hypotension—Epirubicin—prostate cancer	1.9e-05	0.000114	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Docetaxel—prostate cancer	1.9e-05	0.000114	CcSEcCtD
Chenodeoxycholic acid—Confusional state—Doxorubicin—prostate cancer	1.9e-05	0.000114	CcSEcCtD
Chenodeoxycholic acid—Headache—Docetaxel—prostate cancer	1.89e-05	0.000113	CcSEcCtD
Chenodeoxycholic acid—Oedema—Doxorubicin—prostate cancer	1.88e-05	0.000113	CcSEcCtD
Chenodeoxycholic acid—Infection—Doxorubicin—prostate cancer	1.87e-05	0.000112	CcSEcCtD
Chenodeoxycholic acid—Asthenia—Prednisone—prostate cancer	1.87e-05	0.000112	CcSEcCtD
Chenodeoxycholic acid—Vomiting—Capecitabine—prostate cancer	1.86e-05	0.000111	CcSEcCtD
Chenodeoxycholic acid—Musculoskeletal discomfort—Epirubicin—prostate cancer	1.85e-05	0.000111	CcSEcCtD
Chenodeoxycholic acid—Shock—Doxorubicin—prostate cancer	1.85e-05	0.000111	CcSEcCtD
Chenodeoxycholic acid—Nervous system disorder—Doxorubicin—prostate cancer	1.85e-05	0.000111	CcSEcCtD
Chenodeoxycholic acid—Thrombocytopenia—Doxorubicin—prostate cancer	1.84e-05	0.000111	CcSEcCtD
Chenodeoxycholic acid—Rash—Capecitabine—prostate cancer	1.84e-05	0.000111	CcSEcCtD
Chenodeoxycholic acid—Pruritus—Prednisone—prostate cancer	1.84e-05	0.000111	CcSEcCtD
Chenodeoxycholic acid—Insomnia—Epirubicin—prostate cancer	1.84e-05	0.00011	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Capecitabine—prostate cancer	1.84e-05	0.00011	CcSEcCtD
Chenodeoxycholic acid—Tachycardia—Doxorubicin—prostate cancer	1.84e-05	0.00011	CcSEcCtD
Chenodeoxycholic acid—Headache—Capecitabine—prostate cancer	1.83e-05	0.00011	CcSEcCtD
Chenodeoxycholic acid—Skin disorder—Doxorubicin—prostate cancer	1.83e-05	0.00011	CcSEcCtD
Chenodeoxycholic acid—Paraesthesia—Epirubicin—prostate cancer	1.83e-05	0.00011	CcSEcCtD
Chenodeoxycholic acid—Hyperhidrosis—Doxorubicin—prostate cancer	1.82e-05	0.000109	CcSEcCtD
Chenodeoxycholic acid—Dyspnoea—Epirubicin—prostate cancer	1.81e-05	0.000109	CcSEcCtD
Chenodeoxycholic acid—Somnolence—Epirubicin—prostate cancer	1.81e-05	0.000109	CcSEcCtD
Chenodeoxycholic acid—Anorexia—Doxorubicin—prostate cancer	1.79e-05	0.000108	CcSEcCtD
Chenodeoxycholic acid—Nausea—Docetaxel—prostate cancer	1.79e-05	0.000108	CcSEcCtD
Chenodeoxycholic acid—Dyspepsia—Epirubicin—prostate cancer	1.79e-05	0.000108	CcSEcCtD
Chenodeoxycholic acid—Diarrhoea—Prednisone—prostate cancer	1.78e-05	0.000107	CcSEcCtD
Chenodeoxycholic acid—Decreased appetite—Epirubicin—prostate cancer	1.77e-05	0.000106	CcSEcCtD
Chenodeoxycholic acid—Hypotension—Doxorubicin—prostate cancer	1.76e-05	0.000106	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal disorder—Epirubicin—prostate cancer	1.76e-05	0.000105	CcSEcCtD
Chenodeoxycholic acid—Fatigue—Epirubicin—prostate cancer	1.75e-05	0.000105	CcSEcCtD
Chenodeoxycholic acid—Pain—Epirubicin—prostate cancer	1.74e-05	0.000104	CcSEcCtD
Chenodeoxycholic acid—Constipation—Epirubicin—prostate cancer	1.74e-05	0.000104	CcSEcCtD
Chenodeoxycholic acid—Nausea—Capecitabine—prostate cancer	1.73e-05	0.000104	CcSEcCtD
Chenodeoxycholic acid—Dizziness—Prednisone—prostate cancer	1.72e-05	0.000103	CcSEcCtD
Chenodeoxycholic acid—Musculoskeletal discomfort—Doxorubicin—prostate cancer	1.71e-05	0.000103	CcSEcCtD
Chenodeoxycholic acid—Insomnia—Doxorubicin—prostate cancer	1.7e-05	0.000102	CcSEcCtD
Chenodeoxycholic acid—Paraesthesia—Doxorubicin—prostate cancer	1.69e-05	0.000102	CcSEcCtD
Chenodeoxycholic acid—Dyspnoea—Doxorubicin—prostate cancer	1.68e-05	0.000101	CcSEcCtD
Chenodeoxycholic acid—Feeling abnormal—Epirubicin—prostate cancer	1.68e-05	0.000101	CcSEcCtD
Chenodeoxycholic acid—Somnolence—Doxorubicin—prostate cancer	1.67e-05	0.0001	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal pain—Epirubicin—prostate cancer	1.66e-05	9.99e-05	CcSEcCtD
Chenodeoxycholic acid—Dyspepsia—Doxorubicin—prostate cancer	1.66e-05	9.95e-05	CcSEcCtD
Chenodeoxycholic acid—Vomiting—Prednisone—prostate cancer	1.65e-05	9.93e-05	CcSEcCtD
Chenodeoxycholic acid—Rash—Prednisone—prostate cancer	1.64e-05	9.85e-05	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Prednisone—prostate cancer	1.64e-05	9.84e-05	CcSEcCtD
Chenodeoxycholic acid—Decreased appetite—Doxorubicin—prostate cancer	1.64e-05	9.83e-05	CcSEcCtD
Chenodeoxycholic acid—Headache—Prednisone—prostate cancer	1.63e-05	9.79e-05	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal disorder—Doxorubicin—prostate cancer	1.62e-05	9.76e-05	CcSEcCtD
Chenodeoxycholic acid—Fatigue—Doxorubicin—prostate cancer	1.62e-05	9.75e-05	CcSEcCtD
Chenodeoxycholic acid—Urticaria—Epirubicin—prostate cancer	1.62e-05	9.71e-05	CcSEcCtD
Chenodeoxycholic acid—Pain—Doxorubicin—prostate cancer	1.61e-05	9.67e-05	CcSEcCtD
Chenodeoxycholic acid—Constipation—Doxorubicin—prostate cancer	1.61e-05	9.67e-05	CcSEcCtD
Chenodeoxycholic acid—Abdominal pain—Epirubicin—prostate cancer	1.61e-05	9.66e-05	CcSEcCtD
Chenodeoxycholic acid—Body temperature increased—Epirubicin—prostate cancer	1.61e-05	9.66e-05	CcSEcCtD
Chenodeoxycholic acid—Feeling abnormal—Doxorubicin—prostate cancer	1.55e-05	9.31e-05	CcSEcCtD
Chenodeoxycholic acid—Nausea—Prednisone—prostate cancer	1.54e-05	9.28e-05	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal pain—Doxorubicin—prostate cancer	1.54e-05	9.24e-05	CcSEcCtD
Chenodeoxycholic acid—Hypersensitivity—Epirubicin—prostate cancer	1.5e-05	9e-05	CcSEcCtD
Chenodeoxycholic acid—Urticaria—Doxorubicin—prostate cancer	1.49e-05	8.98e-05	CcSEcCtD
Chenodeoxycholic acid—Abdominal pain—Doxorubicin—prostate cancer	1.49e-05	8.94e-05	CcSEcCtD
Chenodeoxycholic acid—Body temperature increased—Doxorubicin—prostate cancer	1.49e-05	8.94e-05	CcSEcCtD
Chenodeoxycholic acid—Asthenia—Epirubicin—prostate cancer	1.46e-05	8.77e-05	CcSEcCtD
Chenodeoxycholic acid—Pruritus—Epirubicin—prostate cancer	1.44e-05	8.64e-05	CcSEcCtD
Chenodeoxycholic acid—Diarrhoea—Epirubicin—prostate cancer	1.39e-05	8.36e-05	CcSEcCtD
Chenodeoxycholic acid—Hypersensitivity—Doxorubicin—prostate cancer	1.39e-05	8.33e-05	CcSEcCtD
Chenodeoxycholic acid—Asthenia—Doxorubicin—prostate cancer	1.35e-05	8.11e-05	CcSEcCtD
Chenodeoxycholic acid—Dizziness—Epirubicin—prostate cancer	1.34e-05	8.08e-05	CcSEcCtD
Chenodeoxycholic acid—Pruritus—Doxorubicin—prostate cancer	1.33e-05	8e-05	CcSEcCtD
Chenodeoxycholic acid—Vomiting—Epirubicin—prostate cancer	1.29e-05	7.77e-05	CcSEcCtD
Chenodeoxycholic acid—Diarrhoea—Doxorubicin—prostate cancer	1.29e-05	7.73e-05	CcSEcCtD
Chenodeoxycholic acid—Rash—Epirubicin—prostate cancer	1.28e-05	7.7e-05	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Epirubicin—prostate cancer	1.28e-05	7.7e-05	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism—SLC5A5—prostate cancer	1.28e-05	0.000101	CbGpPWpGaD
Chenodeoxycholic acid—Headache—Epirubicin—prostate cancer	1.27e-05	7.65e-05	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Biological oxidations—CYP2C19—prostate cancer	1.27e-05	0.0001	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—LPL—prostate cancer	1.27e-05	0.0001	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Gene Expression—SIRT1—prostate cancer	1.27e-05	0.0001	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metapathway biotransformation—CYP2C19—prostate cancer	1.26e-05	9.91e-05	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—GSTA2—prostate cancer	1.25e-05	9.87e-05	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Gene Expression—VDR—prostate cancer	1.25e-05	9.87e-05	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—CYP2E1—prostate cancer	1.25e-05	9.85e-05	CbGpPWpGaD
Chenodeoxycholic acid—Dizziness—Doxorubicin—prostate cancer	1.24e-05	7.47e-05	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Biological oxidations—GSTT1—prostate cancer	1.24e-05	9.81e-05	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—ABCG5—prostate cancer	1.24e-05	9.75e-05	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—SULT1A1—prostate cancer	1.24e-05	9.75e-05	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—NQO1—prostate cancer	1.23e-05	9.74e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Biological oxidations—CYP2A6—prostate cancer	1.23e-05	9.7e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—CYP1A1—prostate cancer	1.23e-05	9.68e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—ERCC2—prostate cancer	1.22e-05	9.6e-05	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—TH—prostate cancer	1.22e-05	9.6e-05	CbGpPWpGaD
Chenodeoxycholic acid—Nausea—Epirubicin—prostate cancer	1.21e-05	7.26e-05	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	1.21e-05	9.54e-05	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—GSTA1—prostate cancer	1.21e-05	9.53e-05	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—CYP3A4—prostate cancer	1.2e-05	9.5e-05	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	1.2e-05	9.45e-05	CbGpPWpGaD
Chenodeoxycholic acid—Vomiting—Doxorubicin—prostate cancer	1.2e-05	7.19e-05	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—Metabolism—HSD3B2—prostate cancer	1.19e-05	9.42e-05	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—GSTO1—prostate cancer	1.19e-05	9.42e-05	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—NAT2—prostate cancer	1.19e-05	9.42e-05	CbGpPWpGaD
Chenodeoxycholic acid—Rash—Doxorubicin—prostate cancer	1.19e-05	7.13e-05	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Doxorubicin—prostate cancer	1.19e-05	7.12e-05	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism—CYP1B1—prostate cancer	1.18e-05	9.34e-05	CbGpPWpGaD
Chenodeoxycholic acid—Headache—Doxorubicin—prostate cancer	1.18e-05	7.08e-05	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Metapathway biotransformation—AKR1C3—prostate cancer	1.18e-05	9.3e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Biological oxidations—CYP17A1—prostate cancer	1.18e-05	9.28e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metapathway biotransformation—CYP17A1—prostate cancer	1.16e-05	9.16e-05	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—GGT1—prostate cancer	1.15e-05	9.04e-05	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—PLCB2—prostate cancer	1.14e-05	9.03e-05	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—LRP2—prostate cancer	1.14e-05	9.03e-05	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—CYP2C18—prostate cancer	1.14e-05	9.03e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—MTHFR—prostate cancer	1.14e-05	9.03e-05	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Gene Expression—ERCC2—prostate cancer	1.14e-05	9.03e-05	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—NCOA1—prostate cancer	1.13e-05	8.91e-05	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Gene Expression—NR3C1—prostate cancer	1.12e-05	8.88e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—PPARA—prostate cancer	1.12e-05	8.86e-05	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—P4HB—prostate cancer	1.12e-05	8.86e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Biological oxidations—NCOA2—prostate cancer	1.12e-05	8.85e-05	CbGpPWpGaD
Chenodeoxycholic acid—Nausea—Doxorubicin—prostate cancer	1.12e-05	6.71e-05	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism—CYP19A1—prostate cancer	1.11e-05	8.78e-05	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—SLC22A1—prostate cancer	1.09e-05	8.62e-05	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—RXRA—prostate cancer	1.07e-05	8.47e-05	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—SULT2A1—prostate cancer	1.06e-05	8.4e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—CAV1—prostate cancer	1.05e-05	8.33e-05	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Gene Expression—PPARA—prostate cancer	1.05e-05	8.32e-05	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—MED12—prostate cancer	1.05e-05	8.26e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Biological oxidations—CYP2E1—prostate cancer	1.04e-05	8.24e-05	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.04e-05	8.24e-05	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—GNG5—prostate cancer	1.04e-05	8.19e-05	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—COMT—prostate cancer	1.03e-05	8.16e-05	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Generic Transcription Pathway—MYC—prostate cancer	1.03e-05	8.15e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metapathway biotransformation—CYP2E1—prostate cancer	1.03e-05	8.13e-05	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—GSTP1—prostate cancer	1.03e-05	8.12e-05	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—ITPR1—prostate cancer	1.01e-05	7.99e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.01e-05	7.96e-05	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—NCOA3—prostate cancer	1e-05	7.89e-05	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—EP300—prostate cancer	9.95e-06	7.86e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Biological oxidations—CYP1B1—prostate cancer	9.9e-06	7.82e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metapathway biotransformation—CYP1B1—prostate cancer	9.76e-06	7.71e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—PIK3CG—prostate cancer	9.6e-06	7.58e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Biological oxidations—GGT1—prostate cancer	9.59e-06	7.57e-05	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—TYMS—prostate cancer	9.56e-06	7.55e-05	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Gene Expression—ESR1—prostate cancer	9.55e-06	7.54e-05	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—HPGDS—prostate cancer	9.54e-06	7.53e-05	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—CYP2C19—prostate cancer	9.48e-06	7.48e-05	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—GSTM1—prostate cancer	9.45e-06	7.46e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Biological oxidations—NCOA1—prostate cancer	9.44e-06	7.46e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Biological oxidations—CYP19A1—prostate cancer	9.31e-06	7.35e-05	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—LPL—prostate cancer	9.28e-06	7.33e-05	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—ACHE—prostate cancer	9.25e-06	7.3e-05	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—GSTT1—prostate cancer	9.25e-06	7.3e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metapathway biotransformation—CYP19A1—prostate cancer	9.18e-06	7.25e-05	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—CYP2A6—prostate cancer	9.14e-06	7.22e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—INS—prostate cancer	9.09e-06	7.18e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Biological oxidations—RXRA—prostate cancer	8.98e-06	7.09e-05	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—CYP1A1—prostate cancer	8.96e-06	7.08e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—CREBBP—prostate cancer	8.91e-06	7.03e-05	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—AKR1C3—prostate cancer	8.89e-06	7.02e-05	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—ERCC2—prostate cancer	8.89e-06	7.02e-05	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—PRKACB—prostate cancer	8.85e-06	6.99e-05	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—CYP17A1—prostate cancer	8.76e-06	6.91e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Biological oxidations—COMT—prostate cancer	8.65e-06	6.83e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Biological oxidations—GSTP1—prostate cancer	8.61e-06	6.8e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metapathway biotransformation—COMT—prostate cancer	8.53e-06	6.74e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metapathway biotransformation—GSTP1—prostate cancer	8.49e-06	6.71e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—PIK3CD—prostate cancer	8.44e-06	6.67e-05	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Gene Expression—CREBBP—prostate cancer	8.37e-06	6.61e-05	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—MTHFR—prostate cancer	8.35e-06	6.6e-05	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—NCOA2—prostate cancer	8.34e-06	6.59e-05	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—PPARA—prostate cancer	8.2e-06	6.47e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—NOS3—prostate cancer	7.97e-06	6.3e-05	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—SLC5A5—prostate cancer	7.96e-06	6.28e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Biological oxidations—GSTM1—prostate cancer	7.91e-06	6.25e-05	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Gene Expression—SERPINE1—prostate cancer	7.85e-06	6.2e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metapathway biotransformation—GSTM1—prostate cancer	7.8e-06	6.16e-05	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—CYP2E1—prostate cancer	7.77e-06	6.14e-05	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—CAV1—prostate cancer	7.71e-06	6.08e-05	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—NQO1—prostate cancer	7.69e-06	6.07e-05	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—TH—prostate cancer	7.58e-06	5.98e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Biological oxidations—CYP1A1—prostate cancer	7.5e-06	5.92e-05	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—CYP3A4—prostate cancer	7.5e-06	5.92e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—HAO1—prostate cancer	7.4e-06	5.85e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metapathway biotransformation—CYP1A1—prostate cancer	7.4e-06	5.84e-05	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—CYP1B1—prostate cancer	7.37e-06	5.82e-05	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	7.36e-06	5.81e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—PIK3CB—prostate cancer	7.36e-06	5.81e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—PTGS2—prostate cancer	7.29e-06	5.76e-05	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—GGT1—prostate cancer	7.14e-06	5.64e-05	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—NCOA1—prostate cancer	7.03e-06	5.55e-05	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—PIK3CG—prostate cancer	7.02e-06	5.54e-05	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—CYP19A1—prostate cancer	6.93e-06	5.47e-05	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—RXRA—prostate cancer	6.69e-06	5.28e-05	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—INS—prostate cancer	6.64e-06	5.25e-05	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—CREBBP—prostate cancer	6.51e-06	5.14e-05	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—COMT—prostate cancer	6.44e-06	5.09e-05	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—GSTP1—prostate cancer	6.41e-06	5.06e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—PTEN—prostate cancer	6.36e-06	5.02e-05	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—ITPR1—prostate cancer	6.31e-06	4.98e-05	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—PIK3CD—prostate cancer	6.17e-06	4.87e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—EP300—prostate cancer	6.06e-06	4.79e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—CBR1—prostate cancer	6.03e-06	4.76e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—GRHL1—prostate cancer	6.03e-06	4.76e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—PSAT1—prostate cancer	6.03e-06	4.76e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—TST—prostate cancer	6.03e-06	4.76e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—ADI1—prostate cancer	6.03e-06	4.76e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—CSAD—prostate cancer	6.03e-06	4.76e-05	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—TYMS—prostate cancer	5.96e-06	4.71e-05	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—GSTM1—prostate cancer	5.89e-06	4.65e-05	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—NOS3—prostate cancer	5.83e-06	4.6e-05	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—LPL—prostate cancer	5.78e-06	4.57e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—UGT2B15—prostate cancer	5.61e-06	4.43e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—CKMT2—prostate cancer	5.61e-06	4.43e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—GRHPR—prostate cancer	5.61e-06	4.43e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—UGT2B17—prostate cancer	5.61e-06	4.43e-05	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—CYP1A1—prostate cancer	5.59e-06	4.41e-05	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—ERCC2—prostate cancer	5.54e-06	4.37e-05	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—PIK3CB—prostate cancer	5.38e-06	4.25e-05	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—PTGS2—prostate cancer	5.33e-06	4.21e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—GSTM3—prostate cancer	5.27e-06	4.16e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—PGAM2—prostate cancer	5.27e-06	4.16e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—SULT2B1—prostate cancer	5.27e-06	4.16e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—MBTPS1—prostate cancer	5.27e-06	4.16e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—AOX1—prostate cancer	5.27e-06	4.16e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—NAGLU—prostate cancer	5.27e-06	4.16e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—RFK—prostate cancer	5.27e-06	4.16e-05	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—MTHFR—prostate cancer	5.21e-06	4.11e-05	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—PPARA—prostate cancer	5.11e-06	4.03e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—AMACR—prostate cancer	5e-06	3.95e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—CYP3A43—prostate cancer	5e-06	3.95e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—NAT1—prostate cancer	5e-06	3.95e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—SRD5A2—prostate cancer	5e-06	3.95e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—DEGS1—prostate cancer	5e-06	3.95e-05	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Gene Expression—MYC—prostate cancer	4.97e-06	3.92e-05	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—CAV1—prostate cancer	4.8e-06	3.79e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—HSD17B1—prostate cancer	4.77e-06	3.77e-05	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—PTEN—prostate cancer	4.65e-06	3.67e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—PIK3CA—prostate cancer	4.49e-06	3.54e-05	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—EP300—prostate cancer	4.43e-06	3.5e-05	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—PIK3CG—prostate cancer	4.37e-06	3.45e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—HPGD—prostate cancer	4.25e-06	3.36e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—B4GALT4—prostate cancer	4.25e-06	3.36e-05	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—INS—prostate cancer	4.14e-06	3.27e-05	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—CREBBP—prostate cancer	4.06e-06	3.2e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—TNFRSF21—prostate cancer	4e-06	3.16e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—CYP7B1—prostate cancer	3.89e-06	3.07e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—MTAP—prostate cancer	3.89e-06	3.07e-05	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—PIK3CD—prostate cancer	3.85e-06	3.04e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—SULT1E1—prostate cancer	3.79e-06	2.99e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—SRD5A1—prostate cancer	3.79e-06	2.99e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—AKT1—prostate cancer	3.67e-06	2.89e-05	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—NOS3—prostate cancer	3.63e-06	2.87e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—HSD17B3—prostate cancer	3.61e-06	2.85e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—ACSL4—prostate cancer	3.61e-06	2.85e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—ARG2—prostate cancer	3.47e-06	2.74e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—PHGDH—prostate cancer	3.47e-06	2.74e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—UMPS—prostate cancer	3.47e-06	2.74e-05	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Gene Expression—AKT1—prostate cancer	3.44e-06	2.72e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—LDHB—prostate cancer	3.4e-06	2.68e-05	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—PIK3CB—prostate cancer	3.35e-06	2.65e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—CYP3A5—prostate cancer	3.34e-06	2.63e-05	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—PTGS2—prostate cancer	3.32e-06	2.62e-05	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—PIK3CA—prostate cancer	3.28e-06	2.59e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—TCN2—prostate cancer	3.22e-06	2.54e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—UCP3—prostate cancer	3.22e-06	2.54e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—GSTA3—prostate cancer	3.22e-06	2.54e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—PDHA1—prostate cancer	3.22e-06	2.54e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—HSD3B1—prostate cancer	3.07e-06	2.43e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—SLC22A3—prostate cancer	3.07e-06	2.43e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—TBXAS1—prostate cancer	2.95e-06	2.33e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—GSTA4—prostate cancer	2.95e-06	2.33e-05	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—PTEN—prostate cancer	2.9e-06	2.29e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—GSTA2—prostate cancer	2.87e-06	2.27e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—ABCG5—prostate cancer	2.84e-06	2.24e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—SULT1A1—prostate cancer	2.84e-06	2.24e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—GSTA1—prostate cancer	2.77e-06	2.19e-05	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—EP300—prostate cancer	2.76e-06	2.18e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—HSD3B2—prostate cancer	2.74e-06	2.16e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—GSTO1—prostate cancer	2.74e-06	2.16e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—NAT2—prostate cancer	2.74e-06	2.16e-05	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—AKT1—prostate cancer	2.68e-06	2.12e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—PLCB2—prostate cancer	2.63e-06	2.07e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—LRP2—prostate cancer	2.63e-06	2.07e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—CYP2C18—prostate cancer	2.63e-06	2.07e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—P4HB—prostate cancer	2.58e-06	2.03e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—SLC22A1—prostate cancer	2.51e-06	1.98e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—SULT2A1—prostate cancer	2.44e-06	1.93e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—MED12—prostate cancer	2.4e-06	1.9e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—GNG5—prostate cancer	2.38e-06	1.88e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—NCOA3—prostate cancer	2.3e-06	1.81e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—HPGDS—prostate cancer	2.19e-06	1.73e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—CYP2C19—prostate cancer	2.18e-06	1.72e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—GSTT1—prostate cancer	2.12e-06	1.68e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—ACHE—prostate cancer	2.12e-06	1.68e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—CYP2A6—prostate cancer	2.1e-06	1.66e-05	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—PIK3CA—prostate cancer	2.04e-06	1.61e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—AKR1C3—prostate cancer	2.04e-06	1.61e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—PRKACB—prostate cancer	2.03e-06	1.6e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—CYP17A1—prostate cancer	2.01e-06	1.59e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—NCOA2—prostate cancer	1.92e-06	1.51e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—SLC5A5—prostate cancer	1.83e-06	1.44e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—CYP2E1—prostate cancer	1.79e-06	1.41e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—NQO1—prostate cancer	1.77e-06	1.39e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—TH—prostate cancer	1.74e-06	1.37e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—CYP1B1—prostate cancer	1.69e-06	1.34e-05	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—AKT1—prostate cancer	1.67e-06	1.32e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—GGT1—prostate cancer	1.64e-06	1.29e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—NCOA1—prostate cancer	1.61e-06	1.28e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—CYP19A1—prostate cancer	1.59e-06	1.26e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—RXRA—prostate cancer	1.54e-06	1.21e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—COMT—prostate cancer	1.48e-06	1.17e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—GSTP1—prostate cancer	1.47e-06	1.16e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—ITPR1—prostate cancer	1.45e-06	1.14e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—TYMS—prostate cancer	1.37e-06	1.08e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—GSTM1—prostate cancer	1.35e-06	1.07e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—LPL—prostate cancer	1.33e-06	1.05e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—CYP1A1—prostate cancer	1.28e-06	1.01e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—ERCC2—prostate cancer	1.27e-06	1e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—MTHFR—prostate cancer	1.2e-06	9.44e-06	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—PPARA—prostate cancer	1.17e-06	9.26e-06	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—CAV1—prostate cancer	1.1e-06	8.71e-06	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—PIK3CG—prostate cancer	1e-06	7.93e-06	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—INS—prostate cancer	9.51e-07	7.51e-06	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—CREBBP—prostate cancer	9.32e-07	7.36e-06	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—PIK3CD—prostate cancer	8.83e-07	6.97e-06	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—NOS3—prostate cancer	8.34e-07	6.59e-06	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—PIK3CB—prostate cancer	7.7e-07	6.08e-06	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—PTGS2—prostate cancer	7.63e-07	6.02e-06	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—PTEN—prostate cancer	6.65e-07	5.25e-06	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—EP300—prostate cancer	6.34e-07	5.01e-06	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—PIK3CA—prostate cancer	4.69e-07	3.71e-06	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—AKT1—prostate cancer	3.83e-07	3.03e-06	CbGpPWpGaD
